Churchill House
137-139 Brent Street
London NW4 4DJ
United Kingdom
https://www.kanabogroup.com
Settore/i: Healthcare
Settore: Medical Care Facilities
Impiegati a tempo pieno: 23
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Avihu Tamir | CEO & Executive Director | 164,91k | N/D | 1981 |
Mr. David Sack | Co-founder | N/D | N/D | N/D |
Mr. Assaf Vardimon | CFO & Company Secretary | N/D | N/D | 1978 |
Mr. Suleman Sacranie | Chief Technology Officer | N/D | N/D | N/D |
Kanabo Group Plc engages in the development and distribution of cannabis-derived solutions for medical and wellness products. It operates through Primary Care and Secondary Care segments. The company offers non- tetrahydrocannabinol products for cannabidiol consumers. It also provides cultivation consultancy, research and development, and telemedicine and tele pharma services, as well as develops and distributes formulations; operates ecommerce platform, the Kanabo Store; and operates Treat It, an online clinic that provides mental health treatments. The company offers its products under the Kanabo brand name. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.
L'ISS Governance QualityScore di Kanabo Group Plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.